Teva lawsuit over generics of Lilly's Forteo brought back by appeals court
Seeking Alpha ·
A federal appeals court on Monday revived a lawsuit brought by Teva Pharmaceutical Industries ( TEVA ) against Eli Lilly ( LLY ) over an agreement that allowed the former to market a generic version of the latter's osteoporosis drug Forteo (teriparatide).
AI 시장 분석
TEVA is facing a retrial over a contract with Eli Lilly regarding genericization of a product.
상승 영향
- Pharmaceuticals — If TEVA's retrial of the Forteo genericization contract goes in their favor, it could lead to a decrease in Eli Lilly's product sales and revenue.
하락 영향
- Pharmaceuticals — If TEVA's retrial of the Forteo genericization contract doesn't go in their favor, it could lead to an increase in generic versions of Eli Lilly's product, potentially decreasing their sales and revenue.
DYAX 전담 분석
The retrial is related to the contract that allowed TEVA to sell a generic version of Eli Lilly's strong product Forteo.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 41% · Bearish (Short) 59%
454 participants